Skip to main content
Sunshine Biopharma, Inc. (SBFM)
NASDAQ: SBFM · Real-Time Price · USD
2.890
+0.040 (1.40%)
Nov 4, 2024, 4:00 PM EST - Market closed

Sunshine Biopharma Revenue

Sunshine Biopharma had revenue of $9.30M in the quarter ending June 30, 2024, with 67.30% growth. This brings the company's revenue in the last twelve months to $30.48M, up 109.82% year-over-year. In the year 2023, Sunshine Biopharma had annual revenue of $24.09M with 454.42% growth.

Revenue (ttm)
$30.48M
Revenue Growth
+109.82%
P/S Ratio
0.00
Revenue / Employee
$692,772
Employees
44
Market Cap
5.78M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202324.09M19.75M454.42%
Dec 31, 20224.35M4.12M1,802.41%
Dec 31, 2021228.43K157.02K219.88%
Dec 31, 202071.41K50.29K238.10%
Dec 31, 201921.12K--
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
SunLink Health Systems 32.44M
Kindly MD 3.10M
Mainz Biomed 917.20K
Exicure 500.00K
Eterna Therapeutics 162.00K
Creative Medical Technology Holdings 17.00K
Revenue Rankings

SBFM News

More News